NEW YORK (GenomeWeb News) – TriLink BioTechnologies today said that it has received a Phase II Small Business Innovation Research grant of around $725,000 to continue its studies of DNA ligase.
The San Diego-based firm said that it will use the funds to continue its research on chemically modified components as a means of enhancing ligation fidelity in a variety of applications including SNP detection, proximity ligation, and sequencing by ligation.